The impact of intrarenal nitric oxide synthase inhibition on renal blood flow and function in mild and severe hyperdynamic sepsis

Critical Care Medicine

Volumn 39, Issue 4, 2011, Pages 770-776

  Ishikawa, Ken ^a   Bellomo, Rinaldo ^b   May, Clive N ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b AUSTIN HEALTH   (Australia)

Author keywords

acute kidney failure; glomerular filtration rate; nitric oxide; nitric oxide synthase; renal blood flow; sepsis

Indexed keywords

CREATININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG ACTIVITY; DRUG EFFICACY; DRUG MECHANISM; ESCHERICHIA COLI; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEPSIS; SODIUM EXCRETION; URINE VOLUME;

EID: 79953193374     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318206c1fb     Document Type: Article

References (37)

1. Uchino S, Bellomo R, Goldsmith D, et al: An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med 2006; 34:1913-1917. (Pubitemid 43982467)
2. Uchino S, Kellum JA, Bellomo R, et al: Acute renal failure in critically ill patients: A multinational, multicenter study. JAMA 2005; 294:813-818. (Pubitemid 41175724)
3. Bagshaw SM, Uchino S, Bellomo R, et al: Septic acute kidney injury in critically ill patients: Clinical characteristics and outcomes. Clin J Am Soc Nephrol 2007; 2:431-439.
4. Bellomo R, Wan L, Langenberg C, et al: Septic acute kidney injury: new concepts. Nephron Exp Nephrol 2008; 109:e95-e100.
5. Schrier RW, Wang W: Acute renal failure and sepsis. N Engl J Med 2004; 351:159-169.
6. Bellomo R, May C, Wan L: Acute renal failure and sepsis. N Engl J Med 2004; 351: 2347-2349; author reply 2347-2349.
7. Lugon JR, Boim MA, Ramos OL, et al: Renal function and glomerular hemodynamics in male endotoxemic rats. Kidney Int 1989; 36: 570-575. (Pubitemid 19239547)
8. van Lambalgen AA, van Kraats AA, van den Bos GC, et al: Development of renal failure in endotoxemic rats: Can it be explained by early changes in renal energy metabolism? Nephron 1993; 65:88-94. (Pubitemid 23241546)
9. Langenberg C, Bellomo R, May C, et al: Renal blood flow in sepsis. Crit Care 2005; 9:R363-374.
10. Levy MM, Fink MP, Marshall JC, et al: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31:1250-1256. (Pubitemid 36444440)
11. Langenberg C, Wan L, Egi M, et al: Renal blood flow and function during recovery from experimental septic acute kidney injury. Intensive Care Med 2007; 33:1614-1618. (Pubitemid 47312480)
12. Annane D, Sanquer S, Sebille V, et al: Compartmentalised inducible nitric-oxide synthase activity in septic shock. Lancet 2000; 355:1143-1148. (Pubitemid 30172936)
13. Cauwels A: Nitric oxide in shock. Kidney Int 2007; 72:557-565. (Pubitemid 47312788)
14. Strand OA, Leone A, Giercksky KE, et al: Nitric oxide indices in human septic shock. Crit Care Med 2000; 28:2779-2785.
15. Lopez A, Lorente JA, Steingrub J, et al: Multiple- center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock. Crit Care Med 2004; 32:21-30. (Pubitemid 38125559)
16. Langenberg C, Wan L, Egi M, et al: Renal blood flow in experimental septic acute renal failure. Kidney Int 2006; 69:1996-2002. (Pubitemid 43924263)
17. Wan L, Langenberg C, Bellomo R, et al: Angiotensin II in experimental hyperdynamic sepsis. Crit Care 2009; 13:R190.
18. Cobb JP, Natanson C, Hoffman WD, et al: N-omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin. J Exp Med 1992; 176:1175-1182.
19. Denton KM, Anderson WP, Sinniah R: Effects of angiotensin II on regional afferent and efferent arteriole dimensions and the glomerular pole. Am J Physiol Regul Integr Comp Physiol 2000; 279:R629-638.
20. Edwards RM, Trizna W, Kinter LB: Renal microvascular effects of vasopressin and vasopressin antagonists. Am J Physiol 1989; 256:F274-F278.
21. James PE, Thomas MP, Jackson SK: Tissue oxygenation in sepsis; new insights from in vivo EPR. NMR Biomed 2004; 17:319-326. (Pubitemid 39255839)
22. Meyer J, Hinder F, Stothert J Jr, et al: Increased organ blood flow in chronic endotoxemia is reversed by nitric oxide synthase inhibition. J Appl Physiol 1994; 76:2785-2793. (Pubitemid 24184809)
23. Johannes T, Mik EG, Klingel K, et al: Effects of 1400W and/or nitroglycerin on renal oxygenation and kidney function during endotoxaemia in anaesthetised rats. Clin Exp Pharmacol Physiol 2009 Apr 27 [Epub ahead of print].
24. Sade K, Schwartz D, Wolman Y, et al: Time course of lipopolysaccharide- induced nitric oxide synthase mRNA expression in rat glomeruli. J Lab Clin Med 1999; 134:471-477. (Pubitemid 29530696)
25. Holmqvist B, Olsson CF, Svensson ML, et al: Expression of nitric oxide synthase isoforms in the mouse kidney: Cellular localization and influence by lipopolysaccharide and Tolllike receptor 4. J Mol Histol 2005; 36: 499-516. (Pubitemid 43829389)
26. Heemskerk S, Pickkers P, Bouw MP, et al: Upregulation of renal inducible nitric oxide synthase during human endotoxemia and sepsis is associated with proximal tubule injury. Clin J Am Soc Nephrol 2006; 1:853-862.
27. Schwartz D, Mendonca M, Schwartz I, et al: Inhibition of constitutive nitric oxide synthase (NOS) by nitric oxide generated by inducible NOS after lipopolysaccharide administration provokes renal dysfunction in rats. J Clin Invest 1997; 100:439-448. (Pubitemid 27349092)
28. Yamaguchi N, Jesmin S, Zaedi S, et al: Timedependent expression of renal vaso-regulatory molecules in LPS-induced endotoxemia in rat. Peptides 2006; 27:2258-2270. (Pubitemid 44189621)
29. Howes LG, Brillante DG: Expert opinion on tilarginine in the treatment of shock. Expert Opin Investig Drugs 2008; 17:1573-1580.
30. Ito S, Ren Y: Evidence for the role of nitric oxide in macula densa control of glomerular hemodynamics. J Clin Invest 1993; 92: 1093-1098. (Pubitemid 23262435)
31. Deng A, Baylis C: Locally produced EDRF controls preglomerular resistance and ultra- filtration coefficient. Am J Physiol 1993; 264: F212-215. (Pubitemid 23068476)
32. Majid DS, Navar LG: Nitric oxide in the control of renal hemodynamics and excretory function. Am J Hypertens 2001; 14:74S-82S. (Pubitemid 32506700)
33. Delles C, Klingbeil AU, Schneider MP, et al: The role of nitric oxide in the regulation of glomerular haemodynamics in humans. Nephrol Dial Transplant 2004; 19:1392-1397. (Pubitemid 38786729)
34. Baylis C, Harton P, Engels K. Endothelial derived relaxing factor controls renal hemodynamics in the normal rat kidney. J Am Soc Nephrol 1990; 1:875-881.
35. Majid DS, Williams A, Kadowitz PJ, et al: Renal responses to intra-arterial administration of nitric oxide donor in dogs. Hypertension 1993; 22:535-541. (Pubitemid 23292160)
36. Cohen RI, Hassell AM, Marzouk K, et al: Renal effects of nitric oxide in endotoxemia. Am J Respir Crit Care Med 2001; 164:1890-1895. (Pubitemid 33152326)
37. Booke M, Hinder F, McGuire R, et al: Nitric oxide synthase inhibition versus norepinephrine for the treatment of hyperdynamic sepsis in sheep. Crit Care Med 1996; 24:835-844 (Pubitemid 26155729)